Scozzafava A - Search Results

1

Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX.

Abbate F, Casini A, Owa T, Scozzafava A, Supuran CT. Abbate F, et al. Among authors: scozzafava a. Bioorg Med Chem Lett. 2004 Jan 5;14(1):217-23. doi: 10.1016/j.bmcl.2003.09.062. Bioorg Med Chem Lett. 2004. PMID: 14684331

2

Carbonic anhydrase activators: high affinity isozymes I, II, and IV activators, incorporating a beta-alanyl-histidine scaffold.

Scozzafava A, Supuran CT. Scozzafava A, et al. J Med Chem. 2002 Jan 17;45(2):284-91. doi: 10.1021/jm010958k. J Med Chem. 2002. PMID: 11784133

3

Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.

Masereel B, Rolin S, Abbate F, Scozzafava A, Supuran CT. Masereel B, et al. Among authors: scozzafava a. J Med Chem. 2002 Jan 17;45(2):312-20. doi: 10.1021/jm0109199. J Med Chem. 2002. PMID: 11784136

4

Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.

Scozzafava A, Menabuoni L, Mincione F, Supuran CT. Scozzafava A, et al. J Med Chem. 2002 Mar 28;45(7):1466-76. doi: 10.1021/jm0108202. J Med Chem. 2002. PMID: 11906288

5

Carbonic anhydrase activators: human isozyme II is strongly activated by oligopeptides incorporating the carboxyterminal sequence of the bicarbonate anion exchanger AE1.

Scozzafava A, Supuran CT. Scozzafava A, et al. Bioorg Med Chem Lett. 2002 Apr 22;12(8):1177-80. doi: 10.1016/s0960-894x(02)00121-x. Bioorg Med Chem Lett. 2002. PMID: 11934582

6

Carbonic anhydrase inhibitors. Preparation of potent sulfonamides inhibitors incorporating bile acid tails.

Scozzafava A, Supuran CT. Scozzafava A, et al. Bioorg Med Chem Lett. 2002 Jun 17;12(12):1551-7. doi: 10.1016/s0960-894x(02)00252-4. Bioorg Med Chem Lett. 2002. PMID: 12039560

7

Targeting cysteine residues of biomolecules: new approaches for the design of antiviral and anticancer drugs.

Scozzafava A, Casini A, Supuran CT. Scozzafava A, et al. Curr Med Chem. 2002 Jun;9(12):1167-85. doi: 10.2174/0929867023370077. Curr Med Chem. 2002. PMID: 12052170 Review.

8

Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design.

Abbate F, Supuran CT, Scozzafava A, Orioli P, Stubbs MT, Klebe G. Abbate F, et al. Among authors: scozzafava a. J Med Chem. 2002 Aug 15;45(17):3583-7. doi: 10.1021/jm011131t. J Med Chem. 2002. PMID: 12166931

9

Sulfonamides and sulfonylated derivatives as anticancer agents.

Casini A, Scozzafava A, Mastrolorenzo A, Supuran LT. Casini A, et al. Among authors: scozzafava a. Curr Cancer Drug Targets. 2002 Mar;2(1):55-75. doi: 10.2174/1568009023334060. Curr Cancer Drug Targets. 2002. PMID: 12188921 Review.

10

Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.

Scozzafava A, Supuran CT. Scozzafava A, et al. Bioorg Med Chem Lett. 2002 Oct 7;12(19):2667-72. doi: 10.1016/s0960-894x(02)00564-4. Bioorg Med Chem Lett. 2002. PMID: 12217351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

579 results

Search Page

Filters